Article
Prolonged survival and phenotypic correction of Akp2(-/-) hypophosphatasia mice by lentiviral gene therapy.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research - 1 Jan 2011
Yamamoto Seiko, Orimo Hideo, Matsumoto Tae, Iijima Osamu, Narisawa Sonoko, Maeda Takahide, Millán José Luis, Shimada Takashi
Abstract excerpt
Hypophosphatasia (HPP) is an inherited systemic skeletal disease caused by mutations in the gene encoding the tissue-nonspecific alkaline phosphatase (TNALP) isozyme. The clinical severity of HPP varies widely, with symptoms including rickets and osteomalacia. TNALP knockout (Akp2(-/-)) mice phenotypically mimic the severe infantile form of HPP; that is, TNALP-deficient mice are born with a normal appearance but...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
